SRDAPRT

Sarda Proteins Share Price

₹102.75
05 November, 2024 08:59 BSE: 519242 NSE: SRDAPRT ISIN: INE995U01011

Start SIP in Sarda Proteins

Start SIP

Sarda Proteins Performance

Day Range

  • Low 0
  • High 0
₹ 102

52 Week Range

  • Low 0
  • High 0
₹ 102
  • Open Price0
  • Previous Close0
  • Volume

Sarda Proteins Chart

  • Over 1 Month -0.04%
  • Over 3 Month + 10.2%
  • Over 6 Month + 149.39%
  • Over 1 Year + 135.18%

Sarda Proteins Key Statistics

Sarda Proteins Financials
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 001001
Operating Expenses Qtr Cr 001001
Operating Profit Qtr Cr 000000
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 000000
Net Profit Qtr Cr 000000
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 16
Operating Expenses Annual Cr 16
Operating Profit Annual in Cr 00
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 00
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 00
Cash from Investing Activity Annual Cr 00
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 00
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 22
Fixed Assets Annual Cr 00
Total Non Current Assets Annual Cr 00
Total Current Assets Annual Cr 22
Total Assets Annual Cr 22
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 99
ROE Annual % 1-1
ROCE Annual % 11
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 10
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Sarda Proteins Technicals

EMA & SMA

Current Price
₹102.75
+ 0 (0%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹95.94
  • 50 Day
  • ₹81.11
  • 100 Day
  • ₹68.75
  • 200 Day
  • ₹61.32
  • 20 Day
  • ₹97.77
  • 50 Day
  • ₹73.56
  • 100 Day
  • ₹62.23
  • 200 Day
  • ₹52.42

Sarda Proteins Resistance and Support

PIVOT
₹102.75
Resistance
First Resistance 102.75
Second Resistance 102.75
Third Resistance 102.75
RSI 92.31
MFI 53.99
MACD Single Line 8.88
MACD 7.86
Support
First Support 102.75
Second Support 102.75
Third Supoort 102.75

Sarda Proteins Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,522 252,200 100
Week 2,522 252,200 100
1 Month
6 Month 6,748 643,642 95.38

Sarda Proteins Result Highlights

Sarda Proteins Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sarda Proteins Corporate Action

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-08-12 Quarterly Results
2024-04-30 Audited Results
2024-02-13 Quarterly Results
2023-11-07 Quarterly Results

Sarda Proteins FAQs

What is Share Price of Sarda Proteins ?

Sarda Proteins share price is ₹102 As on 05 November, 2024 | 08:45

What is the Market Cap of Sarda Proteins ?

The Market Cap of Sarda Proteins is ₹17.7 Cr As on 05 November, 2024 | 08:45

What is the P/E ratio of Sarda Proteins ?

The P/E ratio of Sarda Proteins is -304.7 As on 05 November, 2024 | 08:45

What is the PB ratio of Sarda Proteins ?

The PB ratio of Sarda Proteins is 10.8 As on 05 November, 2024 | 08:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23